Finally, we surveyed the usefulness of the plasma measurement of GLG1 to discriminate CRC and premalignant individuals from controls calculating sensitivity, specificity, and AUC by means of ROC curves. This evidence concerns the gene GLG1 and colorectal carcinoma.